The Global Pap Tests and HPV Tests Market was valued at USD 4.2 Billion in 2023 and is projected to reach USD 6.8 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period (2023–2028). This expansion stems from rising global cervical cancer screening initiatives, increasing HPV vaccination rates, and technological breakthroughs in molecular diagnostics.

With healthcare systems worldwide prioritizing women’s preventive care, cervical cancer screening remains a cornerstone of public health strategies. This analysis highlights the Top 10 Companies in the Pap Tests and HPV Tests Industry—a mix of diagnostic innovators, medical technology leaders, and clinical laboratory providers revolutionizing cervical cancer detection.

---

🔟 1. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: RealTime HR HPV Test, Alinity m System

Abbott stands at the forefront of molecular diagnostics with its FDA-cleared HPV tests detecting 14 high-risk HPV strains. Their automated platforms provide laboratory-standardized results with quick turnaround times.

Clinical Advantages:

• High-throughput processing of up to 1,000 tests per 8-hour shift
• Integration with laboratory workflow systems
• Simultaneous detection of HPV 16, 18, and 12 other high-risk types

Download FREE Sample Report: 2023-2028 Global and Regional Pap Tests and HPV Tests Industry Status and Prospects Professional Market – View in Detailed Research Report

---

9️⃣ 2. Roche Diagnostics

Headquarters: Basel, Switzerland
Key Offering: cobas HPV Test, CINtec PLUS Cytology

Roche’s fully automated platforms provide genotyping for HPV 16/18, the strains responsible for 70% of cervical cancers, plus pooled detection of 12 other high-risk types.

Clinical Advantages:

• FDA-approved for primary HPV screening
• Results in under 4 hours
• Seamless integration with laboratory automation

---

8️⃣ 3. Hologic, Inc.

Headquarters: Marlborough, Massachusetts, USA
Key Offering: ThinPrep Pap Test, Aptima HPV Assay

Hologic’s ThinPrep system revolutionized liquid-based cytology, improving sample collection and diagnostic accuracy while its Aptima HPV test detects E6/E7 mRNA for active infections.

Clinical Advantages:

• 33% increase in lesion detection vs conventional Pap
• Thin-layer technology reduces unsatisfactory specimens
• Combines cytology and molecular testing from single sample

---

7️⃣ 4. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Onclarity HPV Assay, SurePath System

BD offers comprehensive solutions from collection devices to diagnostic instruments, with extended genotyping capabilities that support personalized patient management.

Clinical Advantages:

• Identifies HPV genotypes 16, 18, 31, 45, 51, and 52
• Automated slide preparation reduces manual processing
• Single-vial collection system maintains cell integrity

Download FREE Sample Report: 2023-2028 Global and Regional Pap Tests and HPV Tests Industry Status and Prospects Professional Market – View in Detailed Research Report

---

6️⃣ 5. Qiagen N.V.

Headquarters: Venlo, Netherlands
Key Offering: digene HC2 HPV Test, careHPV Test

Qiagen delivers HPV testing solutions for both high-throughput labs and low-resource settings, including a rapid test that provides results in just 2.5 hours without electricity.

Clinical Advantages:

• CE-marked for self-collected samples
• Point-of-care testing solution for remote areas
• High clinical sensitivity and specificity

---

5️⃣ 6. Quest Diagnostics

Headquarters: Secaucus, New Jersey, USA
Key Offering: HPV co-testing, Primary HPV screening

As the largest US laboratory network, Quest processes millions of cervical cancer tests annually with AI-assisted analysis and proprietary risk assessment algorithms.

Clinical Advantages:

• Nationwide testing coverage
• Comprehensive clinical reporting
• Integrated digital pathology solutions

---

4️⃣ 7. Arbor Vita Corporation

Headquarters: Fremont, California, USA
Key Offering: OncoE6 Cervical Test

Arbor Vita’s innovative approach detects E6 oncoprotein from HPV 16, 18, and 45 – a direct biomarker of persistent infection progressing toward cancer.

Clinical Advantages:

• Point-of-care compatible format
• Identifies women at highest cancer risk
• 30-minute lateral flow test results

---

3️⃣ 8. Seegene Inc.

Headquarters: Seoul, South Korea
Key Offering: Anyplex II HPV28 Detection

Seegene’s multiplex PCR technology enables simultaneous detection and genotyping of 28 HPV strains in a single reaction tube with automated interpretation.

Clinical Advantages:

• Detects all 14 high-risk HPV types
• Includes genotyping for 14 additional strains
• High-throughput testing capability

---

2️⃣ 9. Femasys Inc.

Headquarters: Suwanee, Georgia, USA
Key Offering: FemPap, FemCerv

Femasys focuses on accessible cervical cancer screening with its FDA-approved FemPap liquid-based system and molecular testing technologies.

Clinical Advantages:

• Cost-effective workflow solutions
• Patented collection device designs
• Integrated sample processing

---

1️⃣ 10. Onco Health Corporation

Headquarters: Scottsdale, Arizona, USA
Key Offering: HPV genotyping, Reflex testing

Onco Health provides specialized HPV testing services with comprehensive genotyping panels and clinical decision support tools for practitioners.

Clinical Advantages:

• Customizable testing algorithms
• Result interpretation guidance
• Longitudinal patient risk tracking

Get Full Report Here: 2023-2028 Global and Regional Pap Tests and HPV Tests Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Evolving Landscape of Cervical Cancer Prevention

The Pap tests and HPV diagnostics market is undergoing rapid transformation with WHO’s global strategy to eliminate cervical cancer as a public health problem.

📈 Key Market Trends:

• Shift from cytology-based to molecular HPV testing as primary screening

• Development of point-of-care HPV tests for resource-limited regions

• Integration of AI-assisted cytology interpretation

• Expanding adoption of self-sampling to improve screening participation

Get Full Report Here: 2023-2028 Global and Regional Pap Tests and HPV Tests Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies profiled represent the vanguard of women’s health diagnostics, driving innovations that are making cervical cancer prevention more accurate, accessible, and effective worldwide.